Portfolio Spotlight on Violet: Building Technology and Infrastructure to Increase Health Equity

In our ongoing series spotlighting the equity objectives of leaders within Hopelab’s Ventures portfolio, Gaurang Choksi, Violet’s Founder and CEO, shares insights on the advantages of investing in health equity initiatives. Health inequities currently incur an annual cost of $320 billion to the healthcare industry. Addressing these disparities not only has the potential to reduce costs but also results in improved health outcomes, heightened patient satisfaction, and fosters a more positive and supportive work environment. Gaurang’s leadership is characterized by his lived experience that weaves into Violet’s health equity objectives, aiming to provide culturally competent healthcare journeys for the patients they serve.

Violet has developed a Health Equity Toolkit, a primer for healthcare organizations interested in taking the first step toward investing in health equity. The resource was co-developed with queer, BIPOC, and/or people with disabilities, helping to ensure that their healthcare journeys influence equity practices across organizations. Download the toolkit and check out more clinical resources here.

Violet was founded in 2020 to identify and increase the number of clinicians providing culturally competent care. The credentialing and upskilling platform aims to tackle health disparities, objectively benchmark providers across the industry, and unlock inclusivity within care delivery systems for patients of culturally diverse communities. Hopelab invested in Violet in June 2022.